Growth Metrics

Ingevity (NGVT) Asset Writedowns and Impairment (2016 - 2026)

Ingevity (NGVT) reported Asset Writedowns and Impairment of $2.8 million for Q1 2026, up 2700.0% on a QoQ basis from $100000.0 in Q4 2018.

Ingevity (NGVT) has 4 years of Asset Writedowns and Impairment data on file, last reported at $2.8 million in Q1 2026.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (up 2800.0% YoY) and the FY2025 annual result came in at $109.3 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment grew to $2.8 million in Q1 2026 per NGVT's latest filing, from $100000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.8 million in Q1 2026 and bottomed at $2.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn
10 Ingevity 2.32 Bn 2.14 Bn 116.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.80 Mn
Mar 31, 2026 2.80 Mn
Dec 31, 2018 100,000.00
Dec 31, 2018 100,000.00
Dec 31, 2017 -800,000.00
Dec 31, 2017 -800,000.00
Sep 30, 2017 700,000.00
Sep 30, 2017 700,000.00
Jun 30, 2017 300,000.00
Jun 30, 2017 300,000.00
Mar 31, 2017 100,000.00
Mar 31, 2017 100,000.00
Dec 31, 2016 100,000.00
Dec 31, 2016 100,000.00
Jun 30, 2016 300,000.00
Jun 30, 2016 300,000.00
Mar 31, 2016 100,000.00
Mar 31, 2016 100,000.00